Journal Profile | |
Journal Title | LANCET ONCOLOGY
|
Journal Title Abbreviations | LANCET ONCOL |
ISSN | 1470-2045 |
E-ISSN | 1474-5488 |
h-index | 274 |
CiteScore | CiteScore | SJR | SNIP | CiteScore Rank |
---|
49.40 | 15.650 | 9.486 | Subject field | Quartiles | Rank | Percentile | Category: Medicine Subcategory: Oncology | Q1 | 3 / 331 |
|
|
|
Self-Citation Ratio (2019-2020) | 1.60% |
Official Website | http://www.thelancet.com/journals/lanonc/issue/current |
Online Manuscript Submission | https://www.editorialmanager.com/THELANCETONCOLOGY |
Open Access | No |
Publisher | ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710 |
Subject Area | Medicine |
Country/Area of Publication | UNITED STATES |
Publication Frequency | Monthly |
Year Publication Started | 2000 |
Annual Article Volume | 167 |
Indexing (SCI or SCIE) | Science Citation Index Expanded
|
Link to PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1470-2045%5BISSN%5D |
Average Duration of Peer Review * | Authorized Data from Publisher: Data from Authors: Ordinary, 3-8 Week(s) |
Competitiveness * | Data from Authors: Extremely difficult |
Useful Links | |
*All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. As such they may not reflect the journals' exact competitiveness or speed. |